DVx Inc.

Tokyo Stock Exchange 3079.T

DVx Inc. Return on Assets (ROA) for the year ending March 31, 2024: 0.76%

DVx Inc. Return on Assets (ROA) is 0.76% for the year ending March 31, 2024, a -80.79% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

DVx Inc. Return on Assets (ROA) for the year ending March 31, 2023 was 3.97%, a 2.14% change year over year.
DVx Inc. Return on Assets (ROA) for the year ending March 31, 2022 was 3.89%, a 39.63% change year over year.
DVx Inc. Return on Assets (ROA) for the year ending March 31, 2021 was 2.78%, a -28.44% change year over year.
DVx Inc. Return on Assets (ROA) for the year ending March 31, 2020 was 3.89%, a -25.60% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Tokyo Stock Exchange: 3079.T

DVx Inc.

CEO	Mr. Hiroshi Shibasaki
IPO Date	April 25, 2007
Location	Japan
Headquarters	Mejiro Nakano Building
Employees	316
Sector	Health Care
Industries Medical Instruments Hardware & Electronics Pharmaceuticals

Description

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years